{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T18:28:39Z","timestamp":1649183319102},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,5,29]],"date-time":"2008-05-29T00:00:00Z","timestamp":1212019200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Cardio Med"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1007\/s11936-008-0024-y","type":"journal-article","created":{"date-parts":[[2008,5,28]],"date-time":"2008-05-28T19:57:22Z","timestamp":1212004642000},"page":"223-228","source":"Crossref","is-referenced-by-count":0,"title":["Antiplatelet agents for secondary prevention of stroke"],"prefix":"10.1007","volume":"10","author":[{"given":"Richard A.","family":"Bernstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,5,29]]},"reference":[{"key":"24_CR1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","volume":"324","author":"Antithrombotic Trialists\u2019 Collaboration","year":"2002","unstructured":"Antithrombotic Trialists\u2019 Collaboration: Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002, 324:71\u201386. [Published erratum appears in BMJ 2002, 324:141.]","journal-title":"BMJ"},{"key":"24_CR2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1136\/jnnp.60.2.197","volume":"60","author":"A. Algra","year":"1996","unstructured":"Algra A, van Gijn J: Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemia. J Neurol Neurosurg Psychiatry 1996, 60:197\u2013199.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"24_CR3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/jnnp.66.2.255","volume":"66","author":"A. Algra","year":"1999","unstructured":"Algra A, van Gijn J: Cumulative meta-analysis of aspirin efficacy after cerebral ischaemia of arterial origin. J Neurol Neurosurg Psychiatry 1999, 66:255.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"24_CR4","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1056\/NEJMoa011258","volume":"345","author":"J.P. Mohr","year":"2001","unstructured":"Mohr JP, Thompson JL, Lazar RM, et al.: A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med 2001, 345:1444\u20131451.","journal-title":"N Engl J Med"},{"key":"24_CR5","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa043033","volume":"352","author":"M.I. Chimowitz","year":"2005","unstructured":"Chimowitz MI, Lynn MJ, Howlett-Smith H, et al.: Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005, 352:1305\u20131316.","journal-title":"N Engl J Med"},{"key":"24_CR6","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S1474-4422(06)70685-8","volume":"6","author":"Group TES","year":"2007","unstructured":"Group TES: Medium intensity oral anticoagulants versus aspirin after cerebral ischemia of arterial origin (ESPRIT): a randomized controlled trial. Lancet Neurol 2007, 6:115\u2013124.","journal-title":"Lancet Neurol"},{"key":"24_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-510X(96)00308-5","volume":"143","author":"H.C. Diener","year":"1996","unstructured":"Diener HC, Cunha L, Forbes C, et al.: European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996, 143:1\u201313.","journal-title":"J Neurol Sci"},{"key":"24_CR8","doi-asserted-by":"crossref","first-page":"e409","DOI":"10.1161\/circ.113.10.e409","volume":"113","author":"R.L. Sacco","year":"2006","unstructured":"Sacco RL, Adams R, Albers G, et al.: Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association\/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Circulation 2006, 113:e409\u2013e449.","journal-title":"Circulation"},{"key":"24_CR9","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1001\/archneur.56.9.1087","volume":"56","author":"J.L. Wilterdink","year":"1999","unstructured":"Wilterdink JL, Easton JD: Dipyridamole plus aspirin in cerebrovascular disease. Arch Neurol 1999, 56:1087\u20131092.","journal-title":"Arch Neurol"},{"key":"24_CR10","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0140-6736(06)68734-5","volume":"367","author":"E.S. Group","year":"2006","unstructured":"Group ES, Halkes PH, van Gijn J, et al.: Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet 2006, 367:1665\u20131673. [Published erratum appears in Lancet 2007, 369:274.]","journal-title":"Lancet"},{"key":"24_CR11","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1212\/WNL.54.5.1022","volume":"54","author":"G.W. Albers","year":"2000","unstructured":"Albers GW: Choice of endpoints in antiplatelet trials: which outcomes are most relevant to stroke patients? Neurology 2000, 54:1022\u20131028.","journal-title":"Neurology"},{"key":"24_CR12","first-page":"367","volume":"138","author":"B. Guiraud-Chaumeil","year":"1982","unstructured":"Guiraud-Chaumeil B, Rascol A, David J, et al.: Prevention of recurrences of cerebral ischemic vascular accidents by platelet antiaggregants. Results of a 3-year controlled therapeutic trial [in French]. Rev Neurol (Paris) 1982, 138:367\u2013385.","journal-title":"Rev Neurol (Paris)"},{"key":"24_CR13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1161\/01.STR.14.1.5","volume":"14","author":"M.G. Bousser","year":"1983","unstructured":"Bousser MG, Eschwege E, Haguenau M, et al.: \u201cAICLA\u201d controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia. Stroke 1983, 14:5\u201314.","journal-title":"Stroke"},{"key":"24_CR14","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1161\/01.STR.16.3.406","volume":"16","author":"The American-Canadian Co-Operative Study Group","year":"1985","unstructured":"The American-Canadian Co-Operative Study Group: Persantine Aspirin Trial in cerebral ischemia. Part II: endpoint results. Stroke 1985, 16:406\u2013415.","journal-title":"Stroke"},{"key":"24_CR15","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","volume":"348","author":"CAPRIE Steering Committee","year":"1996","unstructured":"CAPRIE Steering Committee: A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996, 348:1329\u20131339.","journal-title":"Lancet"},{"key":"24_CR16","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0140-6736(04)16721-4","volume":"364","author":"H.C. Diener","year":"2004","unstructured":"Diener HC, Bogousslavsky J, Brass LM, et al.: Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebocontrolled trial. Lancet 2004, 364:331\u2013337.","journal-title":"Lancet"},{"key":"24_CR17","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa060989","volume":"354","author":"D.L. Bhatt","year":"2006","unstructured":"Bhatt DL, Fox KA, Hacke W, et al.: Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 2006, 354:1706\u20131717.","journal-title":"N Engl J Med"},{"key":"24_CR18","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1056\/NEJMp068070","volume":"354","author":"S.W. Lagakos","year":"2006","unstructured":"Lagakos SW: The challenge of subgroup analyses\u2014reporting without distorting. N Engl J Med 2006, 354:1667\u20131669. [Published erratum ppears in N Engl J Med 2006, 355:533.]","journal-title":"N Engl J Med"},{"key":"24_CR19","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1161\/01.STR.0000244754.18106.85","volume":"37","author":"H.C. Diener","year":"2006","unstructured":"Diener HC: How much esprit is in ESPRIT? Stroke 2006, 37:2856\u20132857.","journal-title":"Stroke"},{"key":"24_CR20","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1001\/archneur.62.3.403","volume":"62","author":"R.L. Sacco","year":"2005","unstructured":"Sacco RL, Sivenius J, Diener HC: Efficacy of aspirin plus extended-release dipyridamole in preventing recurrent stroke in high-risk populations. Arch Neurol 2005, 62:403\u2013408.","journal-title":"Arch Neurol"},{"key":"24_CR21","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1161\/CIRCULATIONAHA.106.180944","volume":"115","author":"C.L. Grines","year":"2007","unstructured":"Grines CL, Bonow RO, Casey DE Jr, et al.: Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Circulation 2007, 115:813\u2013818.","journal-title":"Circulation"},{"key":"24_CR22","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","volume":"345","author":"S. Yusuf","year":"2001","unstructured":"Yusuf S, Zhao F, Mehta SR, et al.: Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001, 345:494\u2013502. [Published erratum appears in N Engl J Med 2001, 345:1716.]","journal-title":"N Engl J Med"},{"key":"24_CR23","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S1474-4422(07)70250-8","volume":"6","author":"J. Kennedy","year":"2007","unstructured":"Kennedy J, Hill MD, Ryckborst KJ, et al.: Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial. Lancet Neurol 2007, 6:961\u2013969.","journal-title":"Lancet Neurol"},{"key":"24_CR24","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1161\/01.CIR.0000163561.90680.1C","volume":"111","author":"H.S. Markus","year":"2005","unstructured":"Markus HS, Droste DW, Kaps M, et al.: Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial. Circulation 2005, 111:2233\u20132240.","journal-title":"Circulation"},{"key":"24_CR25","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1159\/000100105","volume":"23","author":"H.C. Diener","year":"2007","unstructured":"Diener HC, Sacco R, Yusuf S; Steering Committee; PRoFESS Study Group: Rationale, design and baseline data of a randomized, double-blind, controlled trial comparing two antithrombotic regimens (a fixed-dose combination of extended-release dipyridamole plus ASA with clopidogrel) and telmisartan versus placebo in patients with strokes: the Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS). Cerebrovasc Dis 2007, 23:368\u2013380.","journal-title":"Cerebrovasc Dis"},{"key":"24_CR26","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/jama.293.7.793-a","volume":"293","author":"B. RA","year":"2005","unstructured":"Bernstein RA, Albers GW: Oral antiplatelet therapy. JAMA 2005, 293:793\u2013794; author reply 794\u2013795.","journal-title":"JAMA"}],"container-title":["Current Treatment Options in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11936-008-0024-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11936-008-0024-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11936-008-0024-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:56:33Z","timestamp":1559436993000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11936-008-0024-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5,29]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["24"],"URL":"https:\/\/doi.org\/10.1007\/s11936-008-0024-y","relation":{},"ISSN":["1092-8464","1534-3189"],"issn-type":[{"value":"1092-8464","type":"print"},{"value":"1534-3189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5,29]]}}}